However, a New Zealand study for CRC patients indicated higher VEGF-B mRNA expression in adenoma than normal tissues and carcinomas, higher VEGF-D mRNA expression in normal tissues than tumor tissues, and no correlations of both VEGF-B and VEGF-D mRNA levels with the patient’s clinicopathological variables7. This evidence concerns the gene VEGFB and adenoma.